- Issuer ticker
-
RIGL
- Reported as of
-
01 Sep 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
03 Sep 2026, 19:01:28 UTC
Filing notes and source
Key filing fact
David A. Santos filed Form 4 for RIGEL PHARMACEUTICALS INC (RIGL) on 03 Sep 2026.
Key facts
- This page summarizes David A. Santos's Form 4 filing for RIGEL PHARMACEUTICALS INC (RIGL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Sep 2026, 19:01.
Change
- Previous filing in this sequence was filed on 22 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001820066
Primary reporting owner
Santos David A
- Relationship
-
EVP, Chief Commercial Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RIGL
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -874
- Change %
- -1.4%
- Price
-
$47.50*
- Shares after
- 61,622
- Date
- 01 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote